Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 1 day agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 12 hours ago“Your risk of encountering somebody with COVID-19 is much greater in a hospital or urgent care than...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 7 hours agoNovavax's Covid Vaccine Novavax protein-based approach offers an alternative for people uneasy with...
I’ve Read Nearly Every Memoir by a Former Trump Official. Fauci’s Is Something Different.
Slate via Yahoo News· 7 hours agoNevertheless, Fauci manages to telegraph Trump’s inadequate response to the COVID crisis without...
Study suggests cancer patients should stay current on COVID-19 boosters
Center for Infectious Disease Research and Policy· 1 day agoAll participants had received a cancer diagnosis from 2015 to 2020. The most common cancers included...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 3 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 6 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Is a COVID summer surge coming? Here’s what CDC data shows
The Hill via Yahoo News· 5 days agoThe uptick in cases may be driven by the new dominant subvariants, like FLiRT and KP.3. While COVID ...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 2 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...